Peer-influenced content. Sources you trust. No registration required. This is HCN.

Caloric and Nutrient Restriction to Augment Chemotherapy Efficacy for Acute Lymphoblastic Leukemia: the IDEAL Trial

From the pages of Blood Advances comes this Clinical Trials & Observations piece discussing the IDEAL trial. Backed by visual abstracts, tables, and charts supporting the data, the article explores two key points in augmenting chemotherapy efficacy: caloric restriction and using insulin and adiponectin as potential biomarkers of B-ALL chemosensitivity.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form